发明名称 Controlled release pharmaceutical compositions of milnacipran
摘要 A controlled release pharmaceutical compositions comprising Milnacipran or pharmaceutically acceptable salts thereof is provided. The pharmaceutical composition comprises an immediate release core comprising Milnacipran or pharmaceutically acceptable salts thereof, pharmaceutically acceptable excipients and a coating on the immediate release core comprising rate controlling agents.
申请公布号 US8916194(B2) 申请公布日期 2014.12.23
申请号 US201113819415 申请日期 2011.08.26
申请人 Lupin Limited 发明人 Kulkarni Shirishkumar;Kulkarni Rajesh;Jadhav Pandharinath;Tiwari Ashish
分类号 A61K31/164;A61K45/00;A61K31/4178;A61K31/165;A61K9/20;A61K45/06;A61K9/28;A61K9/24;A61K31/439 主分类号 A61K31/164
代理机构 The Webb Law Firm 代理人 The Webb Law Firm
主权项 1. A controlled release pharmaceutical composition comprising (i) an immediate release core consisting of Milnacipran or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients, wherein the immediate release core is free of rate controlling agents and (ii) a coating comprising a rate controlling agent on the immediate release core.
地址 Mumbai IN